Trial Profile
A phase I pharmacokinetic and safety study of WP-1303 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Jul 2017
Price :
$35
*
At a glance
- Drugs WP 1303 (Primary)
- Indications Glaucoma; Ocular hypertension
- Focus Adverse reactions; Pharmacokinetics
- 15 Mar 2017 Status changed from recruiting to completed, according to a D. Western Therapeutics Institute media release.
- 04 Nov 2016 New trial record